Overall verdict
Buy
6.7/10
1-year performance
+21.21%
Score breakdown
Up 21.2% over 1 year, 70% of the 52-week range.
Strongest: Profitability 8.0/10. Weakest: Shareholder return 3.2/10.
16 analysts, target +0.3% vs the price.
KT&G Corporation, together with its subsidiaries, engages in the production, distribution, and sale of tobacco products in South Korea, Europe, and internationally. It provides reconstituent tobacco sheets, red ginseng, red ginseng products, other health foods, food and beverage products, health functional food products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio-pharmaceuticals, over-the-counter medicines, and medical supplies and equipment.
In addition, it engages in the trading, real estate, leasing, and housing businesses. Further, the company engages in hotel development and management activities. The company was formerly known as Korea Tobacco and Ginseng Corporation and changed its name to KT&G Corporation in December 2002. KT&G Corporation was founded in 1987 and is headquartered in Daejeon, South Korea.
Sector
Consumer Staples
Industry
Tobacco
Primary listing
Krx
South Korea
CEO
Kyung-Man Bang
Founded
1987
Employees
4 331
Revenue / employee
1.5Md KRW
Next earnings
November 5, 2026 (estimated)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
192400.00 KRW
52-week low
132100.00 KRW
1-year performance
21.21%
Rising
Year-to-date performance
22.66%
Rising
Drawdown
-9.41%
Mild pullback
Position in the 52-week range
70% of range
Range: 190000.00 KRW - 229914.67 KRW (2 methods agree)
The price implies growth of 13.82% per year; the company grows at 1.86%.
Gross margin 46.4%, net margin 20.6%, ROIC 13.5%, ROE 15.2%.
Net margin
20.64%
Exceptional
Sector 8.87%|S&P 12.97%
Gross margin
46.41%
High
Return on equity (ROE)
15.19%
Exceptional
Sector 8.70%|S&P 16.52%
Return on invested capital (ROIC)
13.54%
Exceptional
Free cash flow margin (FCF)
7.10%
Fair
Profit-to-cash conversion (FCF conversion)
0.34x
Low
Margin stability
3.6 pts
Steady
Revenue to net income
Growth
5.9/10Revenue up 9.9% over 1 year, 5.4% a year over 5, EPS 1.9% a year over 5.
Revenue (trailing 12 months)
6.5T KRW
Revenue growth (1y)
9.93%
Moderate
Revenue growth (3y)
12.45%
Moderate
EPS growth (1y)
164.10%
Hyper-growth
EPS CAGR (5y)
1.86%
Low
EPS revisions (3 months)
5.21%
Sharply revised up
Valuation
4.8/10P/E 12.7x, forward P/E 13.5x, EV/EBITDA 11.0x, PEG 6.80. The multiple sits in the 93th percentile of its own 5-year history.
P/E (TTM)
12.7x
Fair
Sector 15.1x|S&P 23.0x
Forward P/E
13.5x
Fair
EV / EBITDA
11.0x
Fair
Sector 9.3x|S&P 14.5x
PEG
6.80
Very expensive
Sector 0.43|S&P 0.86
Fair value (reverse DCF)
194631.03 KRW
Undervalued
P/E vs its own 5-year history
among the 7% highest valuations
At its historical high
Market cap
18.0T KRW
Financial strength
7.2/10Cash covers 82.9% of the debt, net debt/EBITDA 0.3x.
Net debt / EBITDA
0.3x
Very solid
Gearing (net debt / equity)
3.48%
Stretched
Cash
1.5T KRW
Cash / market cap
8.47%
Solid
Cash / total debt
82.90%
Very solid
Net debt
315Md KRW
Equity
9.1T KRW
Closed daily candles, 2 years
Last close on September 23, 2026: 174,300.00 KRW
- MM20173,095.00
- MM50176,092.00
- MM200166,385.00
- RSI 1450.7
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+2.11%
200-day average slope, 3 months
+7.73%
50-day average slope, 1 month
-0.68%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
1.12 % per day
Volatility change
-42.78%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 12918.77 (14) | 12992.43 (13) | 7 068 342 (15) | 1 866 154 (14) | 1 346 475 (13) |
| 2027 | 13983.48 (14) | 13935.55 (14) | 7 456 500 (16) | 1 988 033 (15) | 1 415 650 (13) |
Amounts in millions of KRW, EPS in KRW per share. In brackets, the number of analysts. Consensus as of September 21, 2026.
Same sub-industry: 20 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HMSP | 7.1 | 8.2 | 4.2Md USD | 8.6x | 19.3 % | 12.8 % | 34.4 % | -0.4x | 14.2 % | -19.5 % | ||
| 2 | 2914 | 6.8 | 6.5 | 77.2Md USD | 19.6x | 16.4 % | 20.0 % | 10.7 % | 0.9x | 4.3 % | 43.9 % | ||
| 3 | A033780 | 6.7 | 6.0 | 13.2Md USD | 12.7x | 20.6 % | 9.9 % | 13.5 % | 0.3x | 2.5 % | 21.2 % | ||
| 4 | MO | 5.9 | 5.8 | 115Md USD | 14.5x | 38.9 % | 1.2 % | 39.2 % | 1.4x | 7.9 % | 6.4 % | ||
| 5 | PM | 5.6 | 4.1 | 297Md USD | 27.4x | 25.5 % | 10.2 % | 33.8 % | 2.3x | 4.3 % | 17.1 % | ||
| 6 | IMB | 5.4 | 6.4 | 24.6Md USD | 11.7x | 9.0 % | 2.7 % | 13.4 % | 1.9x | 15.1 % | -20.1 % | ||
| 7 | ITC | 5.4 | 5.7 | 35.3Md USD | 17.0x | 25.9 % | -11.1 % | — | -0.8x | — | -33.3 % | ||
| 8 | BATS | 4.8 | 4.6 | 120Md USD | 14.7x | 24.6 % | -1.0 % | 8.0 % | 2.5x | 6.0 % | 7.8 % | ||
| 9 | 6969 | 4.1 | 2.7 | 7.3Md USD | 45.0x | 7.4 % | 20.9 % | 5.2 % | -6.4x | 0.9 % | -47.3 % |
